心胸比:风湿性心脏病瓣膜置换术前风险评估中被忽视的方法
研究纳入1772例风湿性心脏病瓣膜置换患者,按术前心胸比四分位分4组,探讨心胸比与不良结局的关联。结果显示心胸比>0.6是院内死亡和1年死亡的独立预测因素,Kaplan-Meier曲线显示心胸比>0.6时死亡风险增加。
要点
- 心胸比>0.6是院内死亡的独立预测因素(比值比2.36,P=0.005)。
- 心胸比>0.6是1年死亡的独立预测因素(风险比2.06,P=0.006)。
- 心胸比>0.6时1年累积死亡风险增加(log-rank 16.36,P<0.001)。
核心结论
- 心胸比作为一种简单且可重复的指标,被确定为预测风湿性心脏病瓣膜置换患者不良结局的预后因素。
研究设计与样本
- 回顾性研究,纳入1772例风湿性心脏病行瓣膜置换手术的患者,按术前心胸比四分位分为4组:<0.56(n=349)、0.56-0.61(n=488)、0.61-0.66(n=449)和≥0.66(n=486),心胸比从后前位胸片测量,分析其与不良结局的关联。
主要发现
- 院内死亡率为4.0%(71/1772)。
- 受试者工作特征曲线分析显示,心胸比以0.6为截断值时,检测院内死亡的敏感度为66.2%,特异度为64.0%(曲线下面积0.671,P<0.001)。
- 男性中心胸比>0.6者院内死亡发生率为7.1%,显著高于心胸比未>0.6的男性。
- 女性中心胸比>0.6者院内死亡发生率为5.1%,心胸比未>0.6者为1.9%(P=0.004)。
- 多变量回归显示心胸比>0.6是院内死亡(比值比2.36,P=0.005)和1年死亡(风险比2.06,P=0.006)的独立预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: It is common for patients with rheumatic heart disease to have an enlarged heart. We investigated the prognostic value of cardiothoracic ratio (CTR) in patients with rheumatic heart disease undergoing valve replacement surgery. METHODS: A total of 1772 patients were divided into 4 groups based on the quartiles of preoperative CTR: <0.56 (n = 349), 0.56-0.61 (n = 488), 0.61-0.66 (n = 449) and ≥0.66 (n = 486). The CTR was measured from postero-anterior chest radiographs. We then investigated the association between the CTR and adverse outcomes. RESULTS: In-hospital mortality was 4.0% (71/1772). Analyses of receiver operating characteristic curves showed that, at a cut-off of 0.6, the CTR exhibited 66.2% sensitivity and 64.0% specificity for detecting in-hospital death (area under curve 0.671, P < 0.001). The prevalence of in-hospital death was 7.1% in males with a CTR >0.6, which was significantly higher in males without a CTR. A similar result was observed in females (1.9 vs 5.1%, P = 0.004). Multivariable regression showed that a CTR >0.6 was an independent predictor of in-hospital (odds ratio 2.36, P = 0.005) and 1-year mortality (hazard ratio 2.06, P = 0.006). Kaplan-Meier curves, for the cumulative rate of 1-year mortality among groups, indicated that the risk of death was increased if the CTR >0.6 (log-rank 16.36, P < 0.001). CONCLUSIONS: CTR, as a simple and reproducible indicator, was identified as a prognostic factor for predicting poor outcomes in patients with rheumatic heart disease undergoing valve replacement surgery.
引用
- Jiang L, Chen WG, Geng QS, et al. The cardiothoracic ratio: a neglected preoperative risk-stratified method for patients with rheumatic heart disease undergoing valve replacement surgery. Eur J Cardiothorac Surg. 2019. PMID: 30020427. doi:10.1093/ejcts/ezy255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。